These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25088843)

  • 21. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis.
    Kamogawa N; Miwa K; Toyoda K; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Kitazono T; Boutitie F; Ma H; Ringleb P; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Koga M;
    Stroke; 2024 Apr; 55(4):895-904. PubMed ID: 38456303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
    Aoki J; Sakamoto Y; Kimura K
    J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A; Valvassori L; Nichelatti M;
    Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS).
    Nakagawara J; Minematsu K; Okada Y; Tanahashi N; Nagahiro S; Mori E; Shinohara Y; Yamaguchi T;
    Stroke; 2010 Sep; 41(9):1984-9. PubMed ID: 20651262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Mismatch Concepts for Magnetic Resonance Imaging-Guided Thrombolysis in Unknown Onset Stroke.
    Scheldeman L; Wouters A; Boutitie F; Dupont P; Christensen S; Cheng B; Ebinger M; Endres M; Fiebach JB; Gerloff C; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thijs V; Thomalla G; Lemmens R;
    Ann Neurol; 2020 Jun; 87(6):931-938. PubMed ID: 32227638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries.
    Zhou Z; Yoshimura S; Delcourt C; Lindley RI; You S; Malavera A; Torii-Yoshimura T; Carcel C; Wang X; Chen X; Parsons MW; Demchuk AM; Wardlaw JM; Mair G; Robinson TG; Chalmers J; Xu J; Anderson CS
    Stroke; 2020 Jul; 51(7):2240-2243. PubMed ID: 32568636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MRI and intravenous thrombolysis for unclear-onset stroke during the COVID-19 pandemic: a case report].
    Kamogawa N; Egashira S; Tanaka K; Shiozawa M; Inoue M; Ohta Y; Nishii T; Fukuda T; Koga M
    Rinsho Shinkeigaku; 2020 Oct; 60(10):706-711. PubMed ID: 32893248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
    van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Wallace AC; Gurewich V; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
    Trials; 2022 Aug; 23(1):641. PubMed ID: 35945566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial.
    Koga M; Inoue M; Miwa K; Yoshimura S; Fukuda-Doi M; Aoki J; Asakura K; Kanzawa T; Ohtaki M; Kamiyama K; Yakushiji Y; Igarashi S; Doijiri R; Ito Y; Takagi Y; Sasaki M; Kitazono T; Kimura K; Minematsu K; Yamamoto H; Toyoda K
    J Atheroscler Thromb; 2023 Jan; 30(1):15-22. PubMed ID: 35197420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial.
    Frey BM; Shenas F; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Barow E; Königsberg A; Schlemm E; Pedraza S; Lemmens R; Thijs V; Muir KW; Nighoghossian N; Simonsen CZ; Gerloff C; Thomalla G;
    Stroke; 2023 Jul; 54(7):1718-1725. PubMed ID: 37226772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of intravenous thrombolytic treatment in wake-up stroke: Experiences from a single center.
    Wiśniewski A
    Brain Behav; 2021 Jun; 11(6):e02152. PubMed ID: 33939326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.